triiodothyronine has been researched along with clonazepam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Luckenbaugh, DA; McElroy, SL; Nolen, WA; Pizzarello, S; Post, RM; Rowe, M; Suppes, T | 1 |
1 review(s) available for triiodothyronine and clonazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for triiodothyronine and clonazepam
| Article | Year |
|---|---|
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
Topics: Adult; Ambulatory Care; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Carbonate; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Secondary Prevention; Thyroxine; Treatment Outcome; Triiodothyronine; Valproic Acid | 2010 |